Orchestra BioMed hits right notes with $35M deal
June 18, 2019 at 09:53 AM EDT
The Bucks County company sold the global rights to its non-coated drug-eluting angioplasty balloon to a Japanese medical device manufacturer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|